Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL291P is a pseudogene in the human genome that shares sequence similarity with the functional 7SL RNA gene, which encodes the RNA component of the mammalian signal recognition particle (SRP)[1][3][5][6]. The SRP is essential for directing secretory and membrane proteins to the endoplasmic reticulum during translation. However, RN7SL291P itself does not produce functional RNA or protein, lacks biological activity, and is not known to play any direct role in health or disease[1][3][6]. Pseudogenes like RN7SL291P result from reverse transcription and insertion of RNA back into the genome, leading to truncated and nonfunctional copies of the original gene[3][5]. They are not considered therapeutic targets, biomarkers, or have known safety issues, nor do they interact with drugs or participate in relevant biological pathways. RN7SL291P is a pseudogene, not a receptor, enzyme, transporter, or viable RNA. It has no reported biological or disease function, is not a therapeutic drug target, and has no associated drugs, biomarkers, or safety issues. This entry is correct as a pseudogene, but is incorrect for any therapeutic targeting context.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 291, pseudogene (RN7SL291P).